SEARCH

SEARCH BY CITATION

References

  • 1
    Barbacid, M. 1994. The Trk family of neurotrophin receptors. J. Neurobiol. 25:13861403.
  • 2
    Huang, E. J., and L. F. Reichardt. 2003. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72:609642.
  • 3
    Jones, K. R., I. Farinas, C. Backus, and L. F. Reichardt. 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76:989999.
  • 4
    Ip, N. Y., T. N. Stitt, P. Tapley, R. Klein, D. J. Glass, J. Fandl, et al. 1993. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 10:137149.
  • 5
    Kawamura, K., N. Kawamura, J. Fukuda, J. Kumagai, A. J. Hsueh, and T. Tanaka. 2007. Regulation of preimplantation embryo development by brain-derived neurotrophic factor. Dev. Biol. 311:147158.
  • 6
    Kawamura, K., N. Kawamura, W. Sato, J. Fukuda, J. Kumagai, and T. Tanaka. 2009. Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival. Endocrinology 150:377437782.
  • 7
    Kawamura, K., N. Kawamura, Y. Kumazawa, J. Kumagai, T. Fujimoto, and T. Tanaka. 2011. Brain-derived neurotrophic factor/tyrosine kinase B signaling regulates human trophoblast growth in an in vivo animal model of ectopic pregnancy. Endocrinology 152:10901100.
  • 8
    Kawamura, K., N. Kawamura, Y. Kawagoe, J. Kumagai, T. Fujimoto, and Y. Terada. 2012. Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling. Endocrinology 153:39723981.
  • 9
    Desmet, C. J., and D. S. Peeper. 2006. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell. Mol. Life Sci. 63:755759.
  • 10
    Matsumoto, K., R. K. Wada, J. M. Yamashiro, D. R. Kaplan, and C. J. Thiele. 1995. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 55:17981806.
  • 11
    Au, C. W., M. K. Siu, X. Liao, E. S. Wong, H. Y. Ngan, K. F. Tam, et al. 2009. Tyrosine kinase B receptor and BDNF expression in ovarian cancers – Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett. 281:151161.
  • 12
    Zhang, S., D. Guo, W. Luo, Q. Zhang, Y. Zhang, C. Li, et al. 2010. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. BMC Cancer 10:43.
  • 13
    Kupferman, M. E., T. Jiffar, A. El-Naggar, T. Yilmaz, G. Zhou, T. Xie, et al. 2010. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29:20472059.
  • 14
    Okugawa, Y., K. Tanaka, Y. Inoue, M. Kawamura, A. Kawamoto, J. Hiro, et al. 2013. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br. J. Cancer 108:121130.
  • 15
    Guo, D., X. Hou, H. Zhang, W. Sun, L. Zhu, J. Liang, et al. 2011. More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, suppressed invasion of HepG2 and HCCLM3 cells. J. Exp. Clin. Cancer Res. 30:97.
  • 16
    Huang, Y. T., P. C. Lai, C. C. Wu, C. C. Cheng, and T. H. Chiu. 2010. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells. Int. J. Oncol. 37:943949.
  • 17
    Kermani, P., D. Rafii, D. K. Jin, P. Whitlock, W. Schaffer, A. Chiang, et al. 2005. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J. Clin. Invest. 115:653663.
  • 18
    Douma, S., T. Van Laar, J. Zevenhoven, R. Meuwissen, E. Van Garderen, and D. S. Peeper. 2004. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430:10341039.
  • 19
    Geiger, T. R., and D. S. Peeper. 2005. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res. 65:70337036.
  • 20
    Kawamura, N., K. Kawamura, M. Manabe, and T. Tanaka. 2010. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth. Endocrinology 151:30063014.
  • 21
    Tapley, P., F. Lamballe, and M. Barbacid. 1992. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7:371381.
  • 22
    Ross, A. H., C. A. McKinnon, M. C. Daou, K. Ratliff, and D. E. Wolf. 1995. Differential biological effects of K252 kinase inhibitors are related to membrane solubility but not to permeability. J. Neurochem. 65:27482756.
  • 23
    Kawamura, K., N. Kawamura, S. M. Mulders, M. D. Sollewijn Gelpke, and A. J. Hsueh. 2005. Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos. Proc. Natl. Acad. Sci. USA 102:92069211.
  • 24
    Nakaigawa, N., M. Yao, M. Baba, S. Kato, T. Kishida, K. Hattori, et al. 2006. Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma. Cancer Res. 66:36993705.
  • 25
    Jin, M., K. Udagawa, E. Miyagi, T. Nakazawa, F. Hirahara, H. Yasumitsu, et al. 2001. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo. Gynecol. Oncol. 83:325333.
  • 26
    Matsumoto, S., F. Tanaka, K. Sato, S. Kimura, T. Maekawa, S. Hasegawa, et al. 2009. Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma. Lung Cancer 66:7579.
  • 27
    Librach, C. L., Z. Werb, M. L. Fitzgerald, K. Chiu, N. M. Corwin, R. A. Esteves, et al. 1991. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113:437449.
  • 28
    Staun-Ram, E., S. Goldman, D. Gabarin, and E. Shalev. 2004. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod. Biol. Endocrinol. 2:59.
  • 29
    Lee, C. L., P. C. Chiu, L. Hautala, T. Salo, W. S. Yeung, U. H. Stenman, et al. 2013. Human chorionic gonadotropin and its free beta-subunit stimulate trophoblast invasion independent of LH/hCG receptor. Mol. Cell. Endocrinol. 375:4352.
  • 30
    Fujiwara, H., Y. Nishioka, H. Matsumoto, K. Suginami, A. Horie, H. Tani, et al. 2013. Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion. Int. J. Gynecol. Cancer 23:576582.
  • 31
    Li, Y., Q. Xu, Z. Zhang, S. Liu, C. Shi, and Y. Tan. 2012. The impact of TGF-beta1 on the mRNA expression of TbetaR I, TbetaR II, Smad4 and the invasiveness of the JEG-3 placental choriocarcinoma cell line. Oncol. Lett. 4:13441348.
  • 32
    Suman, P., T. G. Poehlmann, G. J. Prakash, U. R. Markert, and S. K. Gupta. 2009. Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J. Reprod. Immunol. 82:111.
  • 33
    Zhang, Z., Q. Xu, C. Shi, and Y. Li. 2012. Interleukin-12 inhibits cell invasion in choriocarcinoma. Int. J. Mol. Med. 30:5762.
  • 34
    Folkman, J. 2004. Endogenous angiogenesis inhibitors. APMIS 112:496507.
  • 35
    Donovan, M. J., M. I. Lin, P. Wiegn, T. Ringstedt, R. Kraemer, R. Hahn, et al. 2000. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127:45314540.
  • 36
    Kim, H., Q. Li, B. L. Hempstead, and J. A. Madri. 2004. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J. Biol. Chem. 279:3353833546.
  • 37
    Lam, C. T., Z. F. Yang, C. K. Lau, K. H. Tam, S. T. Fan, and R. T. Poon. 2011. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma. Clin. Cancer Res. 17:31233133.
  • 38
    Nakamura, K., K. C. Martin, J. K. Jackson, K. Beppu, C. W. Woo, and C. J. Thiele. 2006. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res. 66:42494255.
  • 39
    Howe, E. N., D. R. Cochrane, and J. K. Richer. 2011. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13:R45.
  • 40
    Bao, W., H. Qiu, T. Yang, X. Luo, H. Zhang, and X. Wan. 2013. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS ONE 8:e70616.
  • 41
    Qiu, L., C. Zhou, Y. Sun, W. Di, E. Scheffler, S. Healey, et al. 2006. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int. J. Oncol. 29:10031011.
  • 42
    Yu, X., L. Liu, B. Cai, Y. He, and X. Wan. 2008. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci. 99:543552.
  • 43
    Cittelly, D. M., I. Dimitrova, E. N. Howe, D. R. Cochrane, A. Jean, N. S. Spoelstra, et al. 2012. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol. Cancer Ther. 11:25562565.
  • 44
    Imam, J. S., J. R. Plyler, H. Bansal, S. Prajapati, S. Bansal, J. Rebeles, et al.2012. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS ONE 7:e52397.